In 2020 the Canadian Immunohistochemistry Quality Control (CIQC) became two organizations: 1) CPQA-AQCP and 2) CBQA-PCAB. They both continue to offer proficiency testing for IHC biomarkers.
In 2020 the CIQC changed from an academic program hosted in the Departments of Pathology at the University of British Columbia and the University of Saskatchewan into two new programs to better reflect the evolving world of biomarker testing in Canadian and international laboratories.
The Canadian Pathology Quality Assurance – Assurance Qualité Canadienne en Pathologie (CPQA-AQCP) is a federal not-for-profit corporation that will focus on routine biomarker testing. The Canadian Biomarker Quality Assurance – Programme canadien d’assurance de la qualité des biomarqueurs (CBQA-PCAB) will focus on research, development, and quality assurance of established and emerging predictive/prognostic biomarkers and will also include proficiency testing for pathologists’ biomarker readout.